BackgroundGlobally, TB is the leading cause of infectious disease morbidity and mortality with many diagnostic uncertainties. Access to affordable and rapid diagnostics remained a major challenge for many developing countries which bear the greatest burden of TB delaying the initiation time to treatment.ObjectiveThis study aimed to assess the GeneXpert MTBRIF assay probe utility for the detection of pulmonary TB and Rifampicin-resistant TB cases in Addis Ababa, Ethiopia.Materials and methodsA cross-sectional study was performed from October 2019 to July 2020 in Saint Peter TB Specialized Hospital in Addis Ababa metropolitan area, Ethiopia. This study enrolled 216 clinically suspected new presumptive pulmonary TB cases confirmed by GeneXpert...
Background: Tuberculosis, mainly caused by Mycobacterium tuberculosis (Mtb), is an ancient human dis...
BACKGROUND:The emergence of pre-extensively and extensively drug-resistant tuberculosis (Pre-XDR/XDR...
AbstractObjective/backgroundWorld Health Organization tuberculosis (TB) indices from 2014 to 2016 sh...
Background: The introduction of a new and rapid molecular diagnostic for tuberculosis (TB) and rifam...
Tuberculosis (TB), which is caused by closely related Mycobacterium tuberculosis complex (MTBC) spec...
Kuma Diriba,1 Ephrem Awulachew,1 Gemechu Churiso2 1Department of Medical Laboratory Sciences, Health...
BackgroundMultidrug-resistant tuberculosis (MDR-TB) continues to be a global health problem. Data on...
Background: The World Health Organization endorsed GeneXpert MTB/RIF (Xpert) assay for the diagnosis...
BackgroundGeneXpert is an effective and rapid molecular system used for tuberculosis (TB) diagnosis....
ABSTRACT: Objectives: Globally, the incidence and mortality of tuberculosis (TB) are declining; howe...
IntroductionMulti-drug resistance is a major challenge in the control of tuberculosis. Despite newer...
IntroductionThe persistence of tuberculosis (TB) infection in some patients after treatment has high...
BACKGROUND: The prevalence of multidrug-resistant tuberculosis (TB) among new and retreatment cases ...
OBJECTIVES : Globally, the incidence and mortality of tuberculosis (TB) are declining; however, low...
Tuberculosis (TB) is caused by M. tuberculosis complex and remains a major global public health prob...
Background: Tuberculosis, mainly caused by Mycobacterium tuberculosis (Mtb), is an ancient human dis...
BACKGROUND:The emergence of pre-extensively and extensively drug-resistant tuberculosis (Pre-XDR/XDR...
AbstractObjective/backgroundWorld Health Organization tuberculosis (TB) indices from 2014 to 2016 sh...
Background: The introduction of a new and rapid molecular diagnostic for tuberculosis (TB) and rifam...
Tuberculosis (TB), which is caused by closely related Mycobacterium tuberculosis complex (MTBC) spec...
Kuma Diriba,1 Ephrem Awulachew,1 Gemechu Churiso2 1Department of Medical Laboratory Sciences, Health...
BackgroundMultidrug-resistant tuberculosis (MDR-TB) continues to be a global health problem. Data on...
Background: The World Health Organization endorsed GeneXpert MTB/RIF (Xpert) assay for the diagnosis...
BackgroundGeneXpert is an effective and rapid molecular system used for tuberculosis (TB) diagnosis....
ABSTRACT: Objectives: Globally, the incidence and mortality of tuberculosis (TB) are declining; howe...
IntroductionMulti-drug resistance is a major challenge in the control of tuberculosis. Despite newer...
IntroductionThe persistence of tuberculosis (TB) infection in some patients after treatment has high...
BACKGROUND: The prevalence of multidrug-resistant tuberculosis (TB) among new and retreatment cases ...
OBJECTIVES : Globally, the incidence and mortality of tuberculosis (TB) are declining; however, low...
Tuberculosis (TB) is caused by M. tuberculosis complex and remains a major global public health prob...
Background: Tuberculosis, mainly caused by Mycobacterium tuberculosis (Mtb), is an ancient human dis...
BACKGROUND:The emergence of pre-extensively and extensively drug-resistant tuberculosis (Pre-XDR/XDR...
AbstractObjective/backgroundWorld Health Organization tuberculosis (TB) indices from 2014 to 2016 sh...